Masimo Corp. (MASI)
NASDAQ:MASI
Want to see MASI full AI Analyst Report?
MASI Stock Chart & Stats
$178.32
$0.33(0.20%)
At close: 4:00 PM EST
$178.32
$0.33(0.20%)
Day’s Range― - ―
52-Week Range$125.94 - $179.99
Previous CloseN/A
Volume102.94K
Average Volume (3M)983.68K
Market Cap
$9.42B
Enterprise Value$9.71B
Total Cash (Recent Filing)$124.60M
Total Debt (Recent Filing)$485.90M
Price to Earnings (P/E)123.1
Beta0.90
Next Earnings
Aug 11, 2026EPS Estimate
1.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.44
Shares Outstanding52,365,807
10 Day Avg. Volume1,142,257
30 Day Avg. Volume983,681
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)9.47
Price to Sales (P/S)4.47
P/FCF Ratio34.52
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue6.23
Enterprise Value/Gross Profit10.09
Enterprise Value/Ebitda28.17
Forecast
1Y Price Target
$180.00Price Target Upside0.94% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)5.96
Revenue Forecast (FY)$1.63B
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumDanaher's agreed acquisition of Masimo carries a substantial premium that makes the offer attractive to shareholders and lowers the chance of a higher competing bid.
Strategic Scale And InnovationDanaher's diagnostics business is positioned to help Masimo scale internationally and accelerate product innovation, supporting potential long-term growth.
Stronger-than-expected ResultsMasimo reported revenue, adjusted earnings, and product shipments above analyst consensus, signaling resilient demand for core products.
Bears Say
Analyst Downgrades And Coverage ChangesSeveral analysts downgraded Masimo or removed ratings because the announced transaction makes prior price targets and company-focused recommendations inapplicable.
Limited Upside From Deal PriceShares trading close to the offer price constrain additional upside for investors, reducing the likelihood of material public-market gains.
Reduced Public DisclosureCancellation of the scheduled earnings call and suspension of certain updates decreases the amount of public company information available to investors.
Masimo News
MASI FAQ
What was Masimo Corp.’s price range in the past 12 months?
Masimo Corp. lowest stock price was $125.94 and its highest was $179.99 in the past 12 months.
What is Masimo Corp.’s market cap?
Masimo Corp.’s market cap is $9.42B.
When is Masimo Corp.’s upcoming earnings report date?
Masimo Corp.’s upcoming earnings report date is Aug 11, 2026 which is in 55 days.
How were Masimo Corp.’s earnings last quarter?
Masimo Corp. released its earnings results on Apr 04, 2026. The company reported $1.07 earnings per share for the quarter, missing the consensus estimate of $1.432 by -$0.362.
Is Masimo Corp. overvalued?
According to Wall Street analysts Masimo Corp.’s price is currently Undervalued.
Does Masimo Corp. pay dividends?
Masimo Corp. pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp. dividends here
What is Masimo Corp.’s EPS estimate?
Masimo Corp.’s EPS estimate is 1.43.
How many shares outstanding does Masimo Corp. have?
Masimo Corp. has 52,365,807 shares outstanding.
What happened to Masimo Corp.’s price movement after its last earnings report?
Masimo Corp. reported an EPS of $1.07 in its last earnings report, missing expectations of $1.432. Following the earnings report the stock price went up 0.074%.
Which hedge fund is a major shareholder of Masimo Corp.?
Currently, no hedge funds are holding shares in MASI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$180.00 (0.94% Upside)
$180.00 (0.94% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.3M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
9.08%
Trailing 12-Months
Asset Growth
-28.36%
Trailing 12-Months
Company Description
Masimo Corp.
Masimo Corporation, established in 1989 and headquartered in Irvine, California, is a global leader in developing, manufacturing, and marketing non-invasive physiological monitoring technologies and hospital automation systems. A cornerstone of their offerings is the Masimo SET pulse oximetry, engineered to overcome the limitations of conventional oximeters by accurately measuring through patient motion and low perfusion. Their advanced Masimo rainbow SET platform further expands capabilities, providing non-invasive monitoring of various hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, respiration rate, hemoglobin concentration, carboxyhemoglobin, and methemoglobin, alongside arterial oxygen saturation and calculated oxygen content and reserve index. Beyond oxygenation, Masimo provides SedLine technology for brain function monitoring via EEG, a diverse range of capnography and gas monitoring products (including external, integrated, and handheld devices), O3 regional oximetry for localized tissue oxygen saturation, and comprehensive hemodynamic monitoring solutions. The company also offers the Masimo Hospital Automation platform, encompassing solutions like Patient SafetyNet and UniView, along with connectivity devices, and nasal high-flow ventilation and neuromodulation systems. Masimo distributes its products worldwide through a direct sales force, distributors, and OEM partners, serving a broad spectrum of clients including hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and directly to consumers for personal health products via its masimopersonalhealth.com e-commerce site.
MASI Stock 12 Month Forecast
Average Price Target
$180.00
▲(0.94% Upside)
Technical Analysis
Ownership Overview
0.04% Insiders
22.76% Mutual Funds
37.67% Other Institutional Investors
28.31% Public Companies and
Individual Investors